Rankings
▼
Calendar
XNCR Q1 2021 Earnings — Xencor, Inc. Revenue & Financial Results | Market Cap Arena
XNCR
Xencor, Inc.
$890M
Q1 2021 Earnings
Healthcare
Biotechnology
Income Statement
Revenue
$34M
+4.9% YoY
Gross Profit
-$7M
-21.9% margin
Operating Income
-$16M
-46.1% margin
Net Income
-$2M
-7.3% margin
EPS (Diluted)
$-0.04
QoQ Revenue Growth
-18.8%
Cash Flow
Operating Cash Flow
-$30M
Free Cash Flow
-$32M
Stock-Based Comp.
$8M
Balance Sheet
Total Assets
$693M
Total Liabilities
$109M
Stockholders' Equity
$584M
Cash & Equivalents
$177M
Year-over-Year Comparison
Metric
Current
Year Ago
Change
Revenue
$34M
$32M
+4.9%
Gross Profit
-$7M
-$2M
-377.9%
Operating Income
-$16M
-$9M
-78.6%
Net Income
-$2M
-$8M
+69.2%
Revenue Segments
Collaboration
$15M
44%
Milestone
$13M
37%
Royalty
$7M
20%
← FY 2021
All Quarters
Q2 2021 →